Solutions For...
Latest Insights
The Benefits of Rapid Diagnostics at the Point of Care
Throughout human history, infectious diseases have been a major cause of suffering and mortality. Remarkably, it was once suggested that half of all humans who have ever lived have been killed by malaria [1]. Equally incredibly, this may represent the…
Read More
Q-POC & TB-HIRA Shortlisted
QuantuMDx are delighted to have been shortlisted in two categories in this year’s Medilink Awards. …
Read More
Diagnosing Influenza at the Point of Care
Influenza, or ‘flu’, is a common respiratory infection usually associated with a seasonal increase during…
Read More
A guide to the UN General Assembly High-Level Meeting on Antimicrobial Resistance 2024
Antimicrobial resistance: A global threat Antimicrobial resistance (AMR) occurs when pathogens (e.g. bacteria, viruses, fungi, and parasites) that cause infections no longer respond to the drugs used to treat them, an issue that poses a significant global public health threat.…
Read More
The Next Pandemic: Q-POC and Disease X
The recent COVID-19 pandemic was a humanitarian and economic disaster, directly contributing to at least…
Read More
QuantuMDx attend 2024 TB Conference, in Baltimore, United States
Paul Fitzpatrick and Jonathan Curry from the QuantuMDx Team recently had the privilege of attending…
Read More
QuantuMDx Showcases Q-POC and TB-Host Immune Response Assay at ESCMID Global 2024
QuantuMDx recently attended ESCMID Global (27 – 30 April 2024), previously known as ECCMID, bringing…
Read More
Get in touch with us
QuantuMDx Group Ltd.
Lugano Building
57 Melbourne Street
Newcastle upon Tyne
NE1 2JQ